125 related articles for article (PubMed ID: 37949119)
1. A multicenter real-world analysis of risk factors, therapeutics, and outcomes of patients with metastatic basal cell carcinoma.
Groover M; Gupta N; Granger E; Forrester VJ; Anstadt EJ; Su W; Heusinkveld L; Chen A; Lukens JN; Silk AW; Vidimos AT; Schoenfeld JD; Koyfman SA; Ruiz ES
J Am Acad Dermatol; 2024 Mar; 90(3):545-551. PubMed ID: 37949119
[TBL] [Abstract][Full Text] [Related]
2. Metastatic basal cell carcinoma: prognosis dependent on anatomic site and spread of disease.
McCusker M; Basset-Seguin N; Dummer R; Lewis K; Schadendorf D; Sekulic A; Hou J; Wang L; Yue H; Hauschild A
Eur J Cancer; 2014 Mar; 50(4):774-83. PubMed ID: 24412051
[TBL] [Abstract][Full Text] [Related]
3. The incidence of metastatic basal cell carcinoma (mBCC) in Denmark, 1997-2010.
Nguyen-Nielsen M; Wang L; Pedersen L; Olesen AB; Hou J; Mackey H; McCusker M; Basset-Seguin N; Fryzek J; Vyberg M
Eur J Dermatol; 2015; 25(5):463-8. PubMed ID: 26105129
[TBL] [Abstract][Full Text] [Related]
4. Metastatic basal cell carcinoma: report of two cases and literature review.
Ting PT; Kasper R; Arlette JP
J Cutan Med Surg; 2005 Jan; 9(1):10-5. PubMed ID: 16208438
[TBL] [Abstract][Full Text] [Related]
5. Metastatic basal cell carcinoma. Report of five cases.
Snow SN; Sahl W; Lo JS; Mohs FE; Warner T; Dekkinga JA; Feyzi J
Cancer; 1994 Jan; 73(2):328-35. PubMed ID: 8293396
[TBL] [Abstract][Full Text] [Related]
6. Characterization and survival of patients with metastatic basal cell carcinoma in the Department of Veterans Affairs: a retrospective electronic health record review.
Stevens VW; Stenehjem DD; Patterson OV; Kamauu AWC; Yim YM; Morlock RJ; DuVall SL
Arch Dermatol Res; 2018 Aug; 310(6):505-513. PubMed ID: 29737404
[TBL] [Abstract][Full Text] [Related]
7. Metastatic basal cell carcinoma presenting as unilateral lymphedema.
Christian MM; Murphy CM; Wagner RF
Dermatol Surg; 1998 Oct; 24(10):1151-3. PubMed ID: 9793528
[TBL] [Abstract][Full Text] [Related]
8. Metastatic basal cell carcinoma in the era of hedgehog signaling pathway inhibitors.
Weiss GJ; Korn RL
Cancer; 2012 Nov; 118(21):5310-9. PubMed ID: 22511370
[TBL] [Abstract][Full Text] [Related]
9. Hedgehog Pathway Inhibitor Therapy for Locally Advanced and Metastatic Basal Cell Carcinoma: A Systematic Review and Pooled Analysis of Interventional Studies.
Jacobsen AA; Aldahan AS; Hughes OB; Shah VV; Strasswimmer J
JAMA Dermatol; 2016 Jul; 152(7):816-24. PubMed ID: 27096888
[TBL] [Abstract][Full Text] [Related]
10. Basosquamous carcinoma and metatypical basal cell carcinoma: a review of treatment with Mohs micrographic surgery.
Allen KJ; Cappel MA; Killian JM; Brewer JD
Int J Dermatol; 2014 Nov; 53(11):1395-403. PubMed ID: 24961583
[TBL] [Abstract][Full Text] [Related]
11. Rate of regional nodal metastases of cutaneous squamous cell carcinoma in the immunosuppressed patient.
McLaughlin EJ; Miller L; Shin TM; Sobanko JF; Cannady SB; Miller CJ; Newman JG
Am J Otolaryngol; 2017; 38(3):325-328. PubMed ID: 28202188
[TBL] [Abstract][Full Text] [Related]
12. Cemiplimab for locally advanced and metastatic basal cell carcinoma.
Damsin T; Lebas E; Marchal N; Rorive A; Nikkels AF
Expert Rev Anticancer Ther; 2022 Mar; 22(3):243-248. PubMed ID: 35175882
[TBL] [Abstract][Full Text] [Related]
13. Squamous Cell Carcinoma with Regional Metastasis to Axilla or Groin Lymph Nodes: a Multicenter Outcome Analysis.
Pang G; Look Hong NJ; Paull G; Dobransky J; Kupper S; Hurton S; Kagedan DJ; Quan ML; Helyer L; Nessim C; Wright FC
Ann Surg Oncol; 2019 Dec; 26(13):4642-4650. PubMed ID: 31440926
[TBL] [Abstract][Full Text] [Related]
14. Nodal skip metastasis in thoracic esophageal squamous cell carcinoma: a cohort study.
Cavallin F; Alfieri R; Scarpa M; Cagol M; Ruol A; Fassan M; Rugge M; Ancona E; Castoro C
BMC Surg; 2017 May; 17(1):49. PubMed ID: 28464907
[TBL] [Abstract][Full Text] [Related]
15. Metastatic Basal Cell Carcinoma: An Unexpected Diagnosis in a Young Patient With Back Pain.
Krooks J; Wilhelm AB; Yassi U; Campbell G
Am J Dermatopathol; 2022 Aug; 44(8):594-601. PubMed ID: 35170470
[TBL] [Abstract][Full Text] [Related]
16. Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study.
Sekulic A; Migden MR; Basset-Seguin N; Garbe C; Gesierich A; Lao CD; Miller C; Mortier L; Murrell DF; Hamid O; Quevedo JF; Hou J; McKenna E; Dimier N; Williams S; Schadendorf D; Hauschild A;
BMC Cancer; 2017 May; 17(1):332. PubMed ID: 28511673
[TBL] [Abstract][Full Text] [Related]
17. Metastatic basal cell carcinoma: a frequent disease with rare clinical evolution.
Carvalho CT; Pinto MM; Plácido AN; Martins A
BMJ Case Rep; 2015 Apr; 2015():. PubMed ID: 25911359
[TBL] [Abstract][Full Text] [Related]
18. Effect of host, tumor, diagnostic, and treatment variables on outcomes in a large cohort with Merkel cell carcinoma.
Asgari MM; Sokil MM; Warton EM; Iyer J; Paulson KG; Nghiem P
JAMA Dermatol; 2014 Jul; 150(7):716-23. PubMed ID: 24807619
[TBL] [Abstract][Full Text] [Related]
19. Clinical and Histopathologic Characteristics of Metastatic and Locally Advanced Cutaneous Basal Cell Carcinomas.
Baker LX; Grilletta E; Zwerner JP; Boyd AS; Wheless L
Am J Dermatopathol; 2021 Dec; 43(12):e169-e174. PubMed ID: 34001746
[TBL] [Abstract][Full Text] [Related]
20. Patterns of distant metastases in 215 Merkel cell carcinoma patients: Implications for prognosis and surveillance.
Lewis CW; Qazi J; Hippe DS; Lachance K; Thomas H; Cook MM; Juhlin I; Singh N; Thuesmunn Z; Takagishi SR; McEvoy A; Doolittle-Amieva C; Bhatia S; Paulson KG; O'Malley RB; Wang CL; Nghiem P
Cancer Med; 2020 Feb; 9(4):1374-1382. PubMed ID: 31883234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
